Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

relacorilant 6 Mifepristone 4 Osilodrostat 3 Corlux 3 Metyrapone 2 Adrenalectomy 2 pembrolizumab 1 Perceived Stress Scale 1 Observation 1 Dabigatran 1 Continuous Glucose Monitoring 1 Abiraterone Acetate 1 ASP3662 1 4-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cushing Syndrome × ASP3662 × Clear all

NCT07296484 2026-05-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡